FDA approves remdesivir as first COVID-19 treatment

The Food and Drug Administration has officially approved Gilead Sciences' antiviral drug remdesivir for use in treatment of coronavirus, according to Fox Business.

President Donald Trump famously touted the drug — which he took — following his COVID-19 diagnosis.

Gilead Chairman and CEO Daniel O'Day commented on the big announcement, calling the development "incredible."

"Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly to help find solutions to this global health crisis. It is incredible to be in the position today, less than one year since the earliest...